MedPath

上海腾瑞制药股份有限公司

Ownership
-
Established
2010-09-27
Employees
-
Market Cap
-
Website
http://www.tenrypharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

外用重组人酸性成纤维细胞生长因子

Product Name
艾夫吉夫
Approval Number
国药准字S20060102
Approval Date
Apr 27, 2023
NMPA

复方磺胺甲噁唑片

Approval Number
国药准字H31020287
Approval Date
Aug 6, 2021
NMPA

盐酸维拉帕米缓释胶囊

Product Name
诺富生
Approval Number
国药准字H20060151
Approval Date
Aug 6, 2021
NMPA

盐酸维拉帕米缓释胶囊

Product Name
诺富生
Approval Number
国药准字H20060152
Approval Date
Aug 6, 2021
NMPA

盐酸维拉帕米缓释胶囊

Product Name
诺富生
Approval Number
国药准字H20060153
Approval Date
Aug 6, 2021
NMPA

铝碳酸镁咀嚼片

Approval Number
国药准字H20093611
Approval Date
May 13, 2019
NMPA

注射用重组人干扰素α2a(酵母)

Product Name
万复洛
Approval Number
国药准字S20000065
Approval Date
Nov 27, 2015
NMPA

注射用重组人干扰素α2b(酵母)

Product Name
万复因
Approval Number
国药准字S20083003
Approval Date
Nov 27, 2015
NMPA

注射用重组人干扰素α2b(酵母)

Product Name
万复因
Approval Number
国药准字S20020080
Approval Date
Nov 27, 2015
NMPA

注射用重组人干扰素α2a(酵母)

Product Name
万复洛
Approval Number
国药准字S20083002
Approval Date
Nov 27, 2015
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.